PTC Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript
Good morning or good afternoon, I guess, and thank you, everyone, for joining the virtual UBS Global Healthcare Conference. I'm Colin Bristow. I'm one of the biotech analyst here at UBS.
It's my pleasure to have PTC Therapeutics here with us today. Speaking on behalf of the company, we have Matt Klein, Chief Development Officer; Eric Pauwels, Chief Business Officer; and Kylie O'Keefe, SVP, Head of Global Commercial and Corporate Strategy. So thank you all for joining us today.
Before we start, if anyone has a question, there is a question functionality in this global meet system. But alternatively, feel free to e-mail me at [email protected], and I can field the question for you.
So with that, I'll hand it over to Matt. Matt, over to you. Thanks.
Thank you, Colin. Let me start with a brief introduction to PTC. For those of you who don't know PTC, we are global commercial diversified
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
